表紙
市場調查報告書

神經修復及再生的全球市場:市場規模,佔有率,趨勢分析 - 各手術(神經移植,神經縫合),產品(生物材料,神經刺激、神經調節設備) 2019年∼2026年

Nerve Repair And Regeneration Market Size, Share & Trends Analysis Report By Surgery (Nerve Grafting, Neurorrhaphy), By Product (Biomaterials Neurostimulation & Neuromodulation Device), And Segment Forecasts, 2019 - 2026

出版商 Grand View Research, Inc. 商品編碼 639947
出版日期 內容資訊 英文 100 Pages
商品交期: 2-3個工作天內
價格
Back to Top
神經修復及再生的全球市場:市場規模,佔有率,趨勢分析 - 各手術(神經移植,神經縫合),產品(生物材料,神經刺激、神經調節設備) 2019年∼2026年 Nerve Repair And Regeneration Market Size, Share & Trends Analysis Report By Surgery (Nerve Grafting, Neurorrhaphy), By Product (Biomaterials Neurostimulation & Neuromodulation Device), And Segment Forecasts, 2019 - 2026
出版日期: 2019年06月04日內容資訊: 英文 100 Pages
簡介

全球神經修復及再生市場在2019年∼2025年間,預測將以10.7%的年複合成長率發展,到2026年成長到178億美元的規模。起因於神經疾病的罹患率上升的治療需求高漲,及政府的資金籌措,償付制度,持續性技術進步促進這個市場成長。

本報告提供全球神經修復及再生市場調查,市場概要,各外科治療、產品、地區的市場規模的變化與預測,市場成長要素及阻礙因素分析,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 調查方法與範圍

  • 市場區隔和範圍
  • 調查方法
  • 資訊採購
  • 資料分析
  • 市場結構與檢驗
  • 模式詳細內容
  • 2次資訊清單
  • 簡稱清單
  • 調查目的

第2章 摘要整理

  • 市場預測
  • 市場區隔預測

第3章 市場變數、趨勢、範圍

  • 市場系列預測
  • 市場區隔
  • 滲透與成長預測
  • 法律規範與償付方案
  • 市場動態
  • 商務環境分析工具
  • 主要交易與策略性聯盟分析

第4章 神經修復及再生市場分析:各產品

  • 市場佔有率分析:各產品
  • 市場區隔儀表板
  • 市場規模的變化與預測:各產品
    • 生物相似藥
    • 神經刺激設備、神經調節設備

第5章 神經修復及再生市場分析:各外科治療

  • 市場佔有率分析:各外科治療
  • 市場區隔儀表板
  • 市場規模的變化與預測:各外科治療
    • 直接性神經修復/神經縫合
    • 幹細胞療法
    • 神經刺激手術/神經調節手術

第6章 神經修復及再生市場分析:各地區

  • 市場佔有率分析:各地區
  • 市場區隔儀表板
  • 地區市場概述
  • 企業清單:各地區
  • SWOT分析
  • 市場趨勢與市場規模的變化與預測
    • 北美
    • 歐洲
    • 亞太地區
    • 中南美
    • 中東、非洲

第7章 競爭分析

  • 參與企業的近幾年的趨勢與影響分析
  • 策略性架構
  • 企業分類(創新者,市場領導者,新興企業)
  • 業者情勢
  • 公開公司
  • 民營企業
  • 企業簡介
    • CYBERONICS, INC
    • MEDTRONIC
    • STRYKER
    • AXOGEN CORPORATION
    • ST. JUDE MEDICAL
    • BAXTER
    • BOSTON SCIENTIFIC CORPORATION
    • POLYGANICS
    • INTEGRA LIFESCIENCES

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 978-1-68038-961-6

The global nerve repair and regeneration market size is expected to reach USD 17.8 billion by 2026 registering a CAGR of 10.7%, according to a new report by Grand View Research, Inc. Demand for neurological disorder therapies owing to increasing incidence and rising awareness about the same will drive the market. Moreover, government funding and reimbursement policies and uninterrupted technological advances are also projected to help boost the market growth.

In January 2016, the EU Horizon 2020 program funded a research project 'Autostem', launched by the NUI Galway's Regenerative Medicine Institute (REMEDI), costing about USD 6.73 million. This project was to develop a robotic stem cell production factory, having an edge over the old traditional techniques. This technique offers prospects of new therapies for a range of diseases, such as cancers, diabetes, and arthritis. Increased R&D and investments by key companies in emerging countries are also driving the market growth. In July 2018, the Stem Cells Australia (SCA) received USD 3 million for stem cell research from the Medical Research Future Fund (MRFF).

In addition, government and private funded organizations are conducting clinical trials to develop a safe and effective therapy for different neurological disorders, such as Stem Cells in Umbilical Blood Infusion for Cerebral Palsy (Phase II) and usage of Polyethylene glycol (PEG) drug (Phase I) to promote axonal fusion technique to repair peripheral nerve injuries in humans.

Furthermore, in October 2017, Stryker Corporation acquired VEXIM, a France-based medical device company. VEXIM's portfolio is complementary to Stryker's Interventional Spine (IVS) portfolio. With this acquisition, Stryker will strengthen its distribution channels in Eastern Europe, Middle East, Asia, and Latin America. In January 2018, Boston Scientific Corporation received U.S. FDA approval for the first and only Spectra WaveWriter spinal cord stimulator system. This system is used for paresthesia-based therapy.

Further key findings from the study suggest:

  • In 2018, neuromodulation and neurostimulation devices segment led the market due to increased cases of Central Nervous System (CNS) disorders and awareness about mental disorders and available treatments
  • Biomaterials is anticipated to expand at the fastest CAGR during the forecast period due to technological advancements and development of biodegradable polymers that can help enhance spinal stabilization, healing of fractures, and reduce hospitalization
  • North America led the market in 2018 owing to technological advancements and advent of new devices. Government initiatives and funding and increased cases of injured CNS, such as injuries to the spinal cord and brain, were some of the major reasons responsible for the region's growth
  • Asia Pacific is expected to be the fastest-growing market during the forecast period. Growing geriatric population, technological advancements, and many unmet medical needs are some of the factors driving the region's growth
  • In February 2016, Indian scientists working for Revita Life Sciences were approved to conduct clinical trials in 20 clinically dead patients to bring specific parts of their CNS back to life
  • Combination of therapies including cocktail of peptides, nerve stimulation techniques, injecting the brain with stem cells and other techniques that were successful in bringing patients out of coma were to be used
  • Existing medical devices were combined with regenerative biological medicines with an objective to achieve such a complex initiative

Some of the key companies include: Boston Scientific, Inc.; Stryker Corporation; St. Jude Medical, Inc.; Medtronic plc.; Baxter International, Inc.; AxoGen, Inc.; Polyganics B.V.; Integra; Cyberonics, Inc.; and Lifesciences Corporation.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation & Scope
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
  • 1.4 Information or Data Analysis
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
    • 1.6.2 Volume Price Analysis (model 2)
  • 1.7 List of Secondary Sources
  • 1.8 List of Abbreviations
  • 1.9 Objectives
    • 1.9.1 Objective - 1:
    • 1.9.2 Objective - 2:

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Lineage outlook
    • 3.1.1 Parent Market Outlook
  • 3.2 Market Segmentation
  • 3.3 Penetration & Growth Prospect Mapping
    • 3.3.1 Penetration & Growth Prospect Mapping
  • 3.4 Regulatory Framework & Reimbursement Scenario
  • 3.5 Market Dynamics
    • 3.5.1 Market Driver Analysis
      • 3.5.1.1 Increasing government fundings and reimbursements
      • 3.5.1.2 Increasing incidences of the neurological disorders
      • 3.5.1.3 Rising medical tourism
    • 3.5.2 Market Restraint Analysis
      • 3.5.2.1 Lack of awareness in the patients for treatment of nerve repair and regeneration
      • 3.5.2.2 High cost of the treatment and unavailability of trained medical personnel
  • 3.6 Business Environment Analysis Tools
    • 3.6.1 Porter's Five Forces Analysis
      • 3.6.1.1 Bargaining power of buyers:Moderate
      • 3.6.1.2 Bargaining power of suppliers: Low
      • 3.6.1.3 Competitive rivalry: High
      • 3.6.1.4 Threat of new entrants: Moderate
      • 3.6.1.5 Threat of substitutes: Moderate
    • 3.6.2 PESTEL Analysis
      • 3.6.2.1 Political & legal landscape
      • 3.6.2.2 Economic landscape
      • 3.6.2.3 Social landscape
      • 3.6.2.4 Technological landscape
      • 3.6.2.5 Environmental landscape
  • 3.7 Major Deals & Strategic Alliances Analysis
    • 3.7.1 Mergers & Acquisitions
    • 3.7.2 Licensing & Partnership

Chapter 4 Nerve Repair And Regeneration Market: Product Analysis

  • 4.1 Nerve Repair And Regeneration Product Market Share Analysis, 2018 & 2026
  • 4.2 Nerve Repair And Regeneration Product Market: Segment Dashboard:
  • 4.3 Market Size & Forecasts And Trend Analyses, 2015 To 2026 For The Product Segment
    • 4.3.1 Biosimilars
      • 4.3.1.1 Biosimilars market, 2015 - 2026 (USD Million)
    • 4.3.2 Neurostimulation & Neuromodulation Devices
      • 4.3.2.1 Spinal cord stimulation devices market, 2015 - 2026 (USD Million)
      • 4.3.2.2. Deep brain stimulation devices market, 2015 - 2026 (USD Million)
      • 4.3.2.3 Sacral nerve stimulation devices market, 2015 - 2026 (USD Million)
      • 4.3.2.4 Vagus nerve stimulation devices market, 2015 - 2026 (USD Million)
      • 4.3.2.5 Gastric electric stimulation devices market, 2015 - 2026 (USD Million)

Chapter 5 Nerve Repair And Regeneration Market: Surgery Analysis

  • 5.1 Nerve Repair And Regeneration Surgery Market Share Analysis, 2018 & 2026
  • 5.2 Nerve Repair And Regeneration Surgery Market: Segment Dashboard
  • 5.3 Market Size & Forecasts And Trend Analyses, 2014 To 2026 For The Surgery
    • 5.3.1 Direct Nerve Repair/Neurorrhaphy
      • 5.3.1.1 Direct nerve repair/Neurorrhaphy market, 2015 - 2026 (USD Million)
    • 5.3.2 Nerve Grafting
      • 5.3.2.1 Nerve grafting market, 2015 - 2026 (USD Million)
    • 5.3.3 Stem Cell Therapy
      • 5.3.3.1 Stem cell therapy market, 2015 - 2026 (USD Million)
    • 5.3.4 Neurostimulation & Neuromodulation Surgeries
      • 5.3.4.1 Neurostimulation & neuromodulation surgeries market, 2015 - 2026 (USD Million)

Chapter 6 Nerve Repair And Regeneration Market: Regional Analysis

  • 6.1 Nerve Repair And Regeneration Regional Market Share Analysis, 2018 & 2026
  • 6.2 Nerve Repair And Regeneration Regional Market: Segment Dashboard
  • 6.3 Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
  • 6.4 List of Players at Regional Level
    • 6.4.1 North America
    • 6.4.2 Europe
    • 6.4.3 Asia Pacific
    • 6.4.4 Latin America
  • 6.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
  • 6.6 Market Size, & Forecasts, And Trend Analysis, 2014 to 2026
    • 6.6.1 North America
    • 6.6.2 North America Nerve Repair And Regeneration Market, 2015 - 2026 (USD Million)
      • 6.6.2.1 U.S.
      • 6.6.2.2 Canada
  • 6.7 Europe
    • 6.7.1 Europe Nerve Repair And Regeneration Market, 2015 - 2026 (USD Million)
      • 6.7.1.1 U.K.
      • 6.7.1.2. Germany
      • 6.7.1.3 France
      • 6.7.1.4. Italy
      • 6.7.1.5 Spain
  • 6.8 Asia Pacific
    • 6.8.1 Asia Pacific Nerve Repair And Regeneration Market, 2015 - 2026 (USD Million)
      • 6.8.1.1 Japan
      • 6.8.1.2 China
      • 6.8.1.3 India
      • 6.8.1.4 Australia
      • 6.8.1.5 South Korea
  • 6.9 Latin America
    • 6.9.1 Latin America Nerve Repair And Regeneration Market, 2015 - 2026 (USD Million)
      • 6.9.1.1 Brazil
      • 6.9.1.2 Mexico
      • 6.9.1.3 Colombia
  • 6.10 Middle East and Africa
    • 6.10.1 MEA Nerve Repair And Regeneration Market, 2015 - 2026 (USD Million)
      • 6.10.1.1 UAE
      • 6.10.1.2 Saudi Arabia
      • 6.10.1.3 South Africa

Chapter 7 Competitive Analysis

  • 7.1 Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2 Strategic Framework/ Competition Categorization (Key Innovators, Market Leaders, Emerging Players
  • 7.3 Vendor Landscape
  • 7.4 Public Companies
    • 7.4.1 Company Market Position Analysis (Revenue, Geographic Presence, Product Portfolio, Strategic Initiatives, Employee Strength)
  • 7.5 Private Companies
    • 7.5.1 Company Market Position Analysis (Geographic Presence, Product Portfolio, Key Alliance, Industry Experience)
  • 7.6 Company Profiles
    • 7.6.1 CYBERONICS, INC
      • 7.6.1.1 Company overview
      • 7.6.1.2 Financial performance
      • 7.6.1.3 Product benchmarking
      • 7.6.1.4 Strategic initiatives
      • 7.6.1.5 SWOT Analysis
    • 7.6.2 MEDTRONIC
      • 7.6.2.1 Company overview
      • 7.6.2.2 Financial performance
      • 7.6.2.3 Product benchmarking
      • 7.6.2.4 Strategic initiatives
      • 7.6.2.5 SWOT Analysis
    • 7.6.3 STRYKER
      • 7.6.3.1 Company overview
      • 7.6.3.2 Financial performance
      • 7.6.3.3 Product benchmarking
      • 7.6.3.4 Strategic initiatives
      • 7.6.3.5 SWOT Analysis
    • 7.6.4 AXOGEN CORPORATION
      • 7.6.4.1 Company overview
      • 7.6.4.2 Financial performance
      • 7.6.4.3 Product benchmarking
      • 7.6.4.4 Strategic initiatives
      • 7.6.4.5 SWOT Analysis
    • 7.6.5 ST. JUDE MEDICAL
      • 7.6.5.1 Company overview
      • 7.6.5.2 Financial performance
      • 7.6.5.3 Product benchmarking
      • 7.6.5.4 Strategic initiatives
      • 7.6.5.5 SWOT Analysis
    • 7.6.6 BAXTER
      • 7.6.6.1 Company overview
      • 7.6.6.2 Financial performance
      • 7.6.6.3 Product benchmarking
      • 7.6.6.4 Strategic initiatives
      • 7.6.6.5 SWOT Analysis
    • 7.6.7 BOSTON SCIENTIFIC CORPORATION
      • 7.6.7.1 Company overview
      • 7.6.7.2 Financial performance
      • 7.6.7.3 Product benchmarking
      • 7.6.7.4 Strategic initiatives
      • 7.6.7.5 SWOT Analysis
    • 7.6.8 POLYGANICS
      • 7.6.8.1 Company overview
      • 7.6.8.2 Financial performance
      • 7.6.8.3 Product benchmarking
      • 7.6.8.4 Strategic initiatives
    • 7.6.9 INTEGRA LIFESCIENCES
      • 7.6.9.1 Company overview
      • 7.6.9.2 Financial performance
      • 7.6.9.3 Product benchmarking
      • 7.6.9.4 Strategic initiatives
      • 7.6.9.5 SWOT Analysis

List of Tables

  • TABLE 1 List of secondary sources
  • TABLE 2 List of Abbreviation
  • TABLE 3 List of players in North America
  • TABLE 4 List of players in Europe
  • TABLE 5 List of players in Asia Pacific
  • TABLE 6 List of players in Latin America
  • TABLE 7 List of players in MEA
  • TABLE 8 North America nerve repair and regeneration market, by country, 2015 - 2026 (USD Million)
  • TABLE 9 North America nerve repair and regeneration market, by product, 2015 - 2026 (USD Million)
  • TABLE 10 North America nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2015 - 2026 (USD Million)
  • TABLE 11 North America nerve repair and regeneration market, by surgery, 2015 - 2026 (USD Million)
  • TABLE 12 U.S. nerve repair and regeneration market, by product 2015 - 2026 (USD Million)
  • TABLE 13 U.S. nerve repair and regeneration market, by eurostimulation and neuromodulation devices, 2015 - 2026 (USD Million)
  • TABLE 14 U.S. nerve repair and regeneration market, by surgery, 2015 - 2026 (USD Million)
  • TABLE 15 Canada. nerve repair and regeneration market, by product, 2015 - 2026 (USD Million)
  • TABLE 16 Canada. nerve repair and regeneration market, by neurostimulation and neuromodulation devices 2015 - 2026 (USD Million)
  • TABLE 17 Canada nerve repair and regeneration market, by surgery, 2015 - 2026 (USD Million)
  • TABLE 18 Europe nerve repair and regeneration market, by country, 2015 - 2026 (USD Million)
  • TABLE 19 Europe nerve repair and regeneration market, by product 2015 - 2026 (USD Million)
  • TABLE 20 Europe nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2015 - 2026 (USD Million)
  • TABLE 21 Europe nerve repair and regeneration market, by surgery, 2015 - 2026 (USD Million)
  • TABLE 22 U.K. nerve repair and regeneration market, by product 2015 - 2026 (USD Million)
  • TABLE 23 U.K. nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2015 - 2026 (USD Million)
  • TABLE 24 U.K. nerve repair and regeneration market, by surgery, 2015 - 2026 (USD Million)
  • TABLE 25 Germany nerve repair and regeneration market, by product, 2015 - 2026 (USD Million)
  • TABLE 26 Germany nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2015 - 2026 (USD Million)
  • TABLE 27 Germany nerve repair and regeneration market, by surgery, 2015 - 2026 (USD Million)
  • TABLE 28 France nerve repair and regeneration market, by product, 2015 - 2026 (USD Million)
  • TABLE 29 France nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2015 - 2026 (USD Million)
  • TABLE 30 France nerve repair and regeneration market, by surgery, 2015 - 2026 (USD Million)
  • TABLE 31 Italy nerve repair and regeneration market, by product, 2015 - 2026 (USD Million)
  • TABLE 32 Italy nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2015 - 2026 (USD Million)
  • TABLE 33 Italy nerve repair and regeneration Market, by surgery, 2015 - 2026 (USD Million)
  • TABLE 34 Spain nerve repair and regeneration market, by product, 2015 - 2026 (USD Million)
  • TABLE 35 Spain nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2015 - 2026 (USD Million)
  • TABLE 36 Spain nerve repair and regeneration Market, by surgery, 2015 - 2026 (USD Million)
  • TABLE 37 Asia Pacific nerve repair and regeneration market, by country, 2015 - 2026 (USD Million)
  • TABLE 38 Asia Pacific nerve repair and regeneration market, by product 2015 - 2026 (USD Million)
  • TABLE 39 Asia Pacific nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2015 - 2026 (USD Million)
  • TABLE 40 Asia Pacific nerve repair and regeneration market, by surgery, 2015 - 2026 (USD Million)
  • TABLE 41 Japan nerve repair and regeneration market, by product 2015 - 2026 (USD Million)
  • TABLE 42 Japan nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2015 - 2026 (USD Million)
  • TABLE 43 Japan nerve repair and regeneration market, by surgery, 2015 - 2026 (USD Million)
  • TABLE 44 China nerve repair and regeneration market, by product 2015 - 2026 (USD Million)
  • TABLE 45 China nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2015 - 2026 (USD Million)
  • TABLE 46 China nerve repair and regeneration market, by surgery, 2015 - 2026 (USD Million)
  • TABLE 47 India nerve repair and regeneration market, by product, 2015 - 2026 (USD Million)
  • TABLE 48 India nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2015 - 2026 (USD Million)
  • TABLE 49 India nerve repair and regeneration market, by surgery, 2015 - 2026 (USD Million)
  • TABLE 50 Australia nerve repair and regeneration market, by product 2015 - 2026 (USD Million)
  • TABLE 51 Australia nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2015 - 2026 (USD Million)
  • TABLE 52 Australia nerve repair and regeneration market, by surgery, 2015 - 2026 (USD Million)
  • TABLE 53 South Korea nerve repair and regeneration market, by product 2015 - 2026 (USD Million)
  • TABLE 54 South Korea nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2015 - 2026 (USD Million)
  • TABLE 55 South Korea nerve repair and regeneration market, by surgery, 2015 - 2026 (USD Million)
  • TABLE 56 Latin America nerve repair and regeneration market, by country, 2015 - 2026 (USD Million)
  • TABLE 57 Latin America nerve repair and regeneration market, by product, 2015 - 2026 (USD Million)
  • TABLE 58 Latin America nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2015 - 2026 (USD Million)
  • TABLE 59 Latin America nerve repair and regeneration market, by surgery, 2015 - 2026 (USD Million)
  • TABLE 60 Brazil nerve repair and regeneration market, by product 2015 - 2026 (USD Million)
  • TABLE 61 Brazil nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2015 - 2026 (USD Million)
  • TABLE 62 Brazil. nerve repair and regeneration market, by surgery, 2015 - 2026 (USD Million)
  • TABLE 63 Mexico nerve repair and regeneration market, by product 2015 - 2026 (USD Million)
  • TABLE 64 Mexico nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2015 - 2026 (USD Million)
  • TABLE 65 Mexico nerve repair and regeneration market, by surgery, 2015 - 2026 (USD Million)
  • TABLE 66 MEA nerve repair and regeneration market, by country, 2015 - 2026 (USD Million)
  • TABLE 67 MEA nerve repair and regeneration market, by product 2015 - 2026 (USD Million)
  • TABLE 68 MEA nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2015 - 2026 (USD Million)
  • TABLE 69 MEA nerve repair and regeneration market, by surgery, 2015 - 2026 (USD Million)
  • TABLE 70 South Africa nerve repair and regeneration market, by product 2015 - 2026 (USD Million)
  • TABLE 71 South Africa nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2015 - 2026 (USD Million)
  • TABLE 72 South Africa nerve repair and regeneration market, by surgery, 2015 - 2026 (USD Million)
  • TABLE 73 UAE nerve repair and regeneration market, by product 2015 - 2026 (USD Million)
  • TABLE 74 UAE nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2015 - 2026 (USD Million)
  • TABLE 75 UAE nerve repair and regeneration market, by surgery, 2015 - 2026 (USD Million)
  • TABLE 76 Saudi Arabia nerve repair and regeneration market, by product 2015 - 2026 (USD Million)
  • TABLE 77 Saudi Arabia nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2015 - 2026 (USD Million)
  • TABLE 78 Saudi Arabia. Nerve repair and regeneration market, by surgery, 2015 - 2026 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain based sizing & forecasting
  • FIG. 6 QFD modelling for market share assessment
  • FIG. 7 Market formulation & validation
  • FIG. 8 Market outlook
  • FIG. 9 Nerve repair and regeneration market segmentation
  • FIG. 10 Penetration & growth prospect mapping
  • FIG. 11 Market trends & outlook
  • FIG. 12 Market driver relevance analysis (Current & future impact)
  • FIG. 13 Market restraint relevance analysis (Current & future impact)
  • FIG. 14 PORTER'S five forces analysis
  • FIG. 15 PESTLE analysis
  • FIG. 16 Nerve repair and regeneration product market share analysis, 2018 & 2026
  • FIG. 17 Nerve repair and regeneration product market: Segment dashboard
  • FIG. 18 Biosimilars nerve repair and regeneration market, 2015 - 2026 (USD Million)
  • FIG. 19 Neurostimulation and neuromodulation devices nerve repair and regeneration market, 2015 - 2026 (USD Million)
  • FIG. 20 Nerve repair and regeneration surgery market share analysis, 2018 & 2026
  • FIG. 21 Nerve repair and regeneration surgery market: Segment dashboard
  • FIG. 22 Direct nerve repair/Neurorrhaphy market, 2015 - 2026 (USD Million)
  • FIG. 23 Nerve grafting market, 2015 - 2026 (USD Million)
  • FIG. 24 Stem cell therapy market, 2015 - 2026 (USD Million)
  • FIG. 25 Neurostimulation and neuromodulation surgeries market, 2015 - 2026 (USD Million)
  • FIG. 26 Nerve repair and regeneration regional market share analysis, 2018 & 2026
  • FIG. 27 Nerve repair and regeneration regional market: Segment dashboard
  • FIG. 28 Nerve repair and regeneration market place: Key takeaways
  • FIG. 29 North America Nerve repair and regeneration market, 2015 - 2026 (USD Million)
  • FIG. 30 U.S. Nerve repair and regeneration market, 2015 - 2026 (USD Million)
  • FIG. 31 Canada Nerve repair and regeneration market, 2015 - 2026 (USD Million)
  • FIG. 32 Europe Nerve repair and regeneration market, 2015 - 2026 (USD Million)
  • FIG. 33 U.K. Nerve repair and regeneration market, 2015 - 2026 (USD Million)
  • FIG. 34 Germany Nerve repair and regeneration market, 2015 - 2026 (USD Million)
  • FIG. 35 France Nerve repair and regeneration market, 2015 - 2026 (USD Million)
  • FIG. 36 Italy Nerve repair and regeneration market, 2015 - 2026 (USD Million)
  • FIG. 37 Spain Nerve repair and regeneration market, 2015 - 2026 (USD Million)
  • FIG. 38 Asia Pacific Nerve repair and regeneration market, 2015 - 2026 (USD Million)
  • FIG. 39 Japan Nerve repair and regeneration market, 2015 - 2026 (USD Million)
  • FIG. 40 China Nerve repair and regeneration market, 2015 - 2026 (USD Million)
  • FIG. 41 India Nerve repair and regeneration market, 2015 - 2026 (USD Million)
  • FIG. 42 Australia Nerve repair and regeneration market, 2015 - 2026 (USD Million)
  • FIG. 43 South Korea Nerve repair and regeneration market, 2015 - 2026 (USD Million)
  • FIG. 44 Colombia Nerve repair and regeneration market, 2015 - 2026 (USD Million)
  • FIG. 45 Latin America Nerve repair and regeneration market, 2015 - 2026 (USD Million)
  • FIG. 46 Brazil Nerve repair and regeneration market, 2015 - 2026 (USD Million)
  • FIG. 47 Mexico Nerve repair and regeneration market, 2015 - 2026 (USD Million)
  • FIG. 48 MEA Nerve repair and regeneration market, 2015 - 2026 (USD Million)
  • FIG. 49 South Africa Nerve repair and regeneration market, 2015 - 2026 (USD Million)
  • FIG. 50 UAE Nerve repair and regeneration market, 2015 - 2026 (USD Million)
  • FIG. 51 Saudi Arabia Nerve repair and regeneration market, 2015 - 2026 (USD Million)
  • FIG. 52 Strategy framework
  • FIG. 53 Strategy framework / Competition categorization
  • FIG. 54 Strategy mapping
  • FIG. 55 Company market position analysis (revenue, geographic presence, product portfolio, strategic initiatives, employee strength)
  • FIG. 56 Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
Back to Top